4//SEC Filing
Rice William G. 4
Accession 0001567619-21-013023
CIK 0000882361other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:07 PM ET
Size
5.4 KB
Accession
0001567619-21-013023
Insider Transaction Report
Form 4
Rice William G.
DirectorChair, President & CEO
Transactions
- Purchase
Common shares
2021-07-02$3.29/sh+6,081$19,998→ 303,604 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.2777 to $3.2980, inclusive. The reporting person undertakes to provide to Aptose Biosciences Inc., any security holder of Aptose Biosciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001761487
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 5:07 PM ET
- Size
- 5.4 KB